Financial results - ANDIMED S.R.L.

Financial Summary - Andimed S.r.l.
Unique identification code: 15386512
Registration number: J40/5503/2003
Nace: 8622
Sales - Ron
112.660
Net Profit - Ron
7.132
Employee
3
The most important financial indicators for the company Andimed S.r.l. - Unique Identification Number 15386512: sales in 2023 was 112.660 euro, registering a net profit of 7.132 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Andimed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 71.340 77.514 96.297 100.585 105.204 99.358 96.147 96.442 109.018 112.660
Total Income - EUR 71.345 77.519 96.303 100.585 105.204 99.354 96.149 96.443 109.019 117.478
Total Expenses - EUR 69.361 66.921 81.298 96.907 82.201 80.389 94.748 92.896 108.022 109.171
Gross Profit/Loss - EUR 1.984 10.598 15.004 3.678 23.004 18.965 1.400 3.547 996 8.307
Net Profit/Loss - EUR 1.183 8.474 14.041 2.672 21.951 17.971 439 2.583 -39 7.132
Employees 5 0 4 4 4 4 4 4 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 3.7%, from 109.018 euro in the year 2022, to 112.660 euro in 2023. The Net Profit increased by 7.132 euro, from 0 euro in 2022, to 7.132 in the last year.

Check the financial reports for the company - Andimed S.r.l.

Rating financiar

Financial Rating -
Andimed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Andimed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Andimed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Andimed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Andimed S.r.l. - CUI 15386512

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 42.344 30.904 19.797 9.422 5.118 5.314 6.516 5.496 93.145 67.270
Current Assets 70.035 68.266 82.433 76.233 64.602 53.460 10.414 12.544 14.900 11.722
Inventories 147 148 0 0 0 0 33 33 0 984
Receivables 16.821 15.507 18.236 11.189 10.289 1.648 2.253 1.405 1.688 7.307
Cash 53.067 52.610 64.197 65.045 54.314 51.812 8.127 11.106 13.212 3.431
Shareholders Funds 70.757 79.821 93.048 70.289 59.448 50.058 7.783 10.193 10.185 17.286
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 41.622 19.349 9.182 15.672 10.967 8.743 9.220 7.993 97.931 61.706
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 11.722 euro in 2023 which includes Inventories of 984 euro, Receivables of 7.307 euro and cash availability of 3.431 euro.
The company's Equity was valued at 17.286 euro, while total Liabilities amounted to 61.706 euro. Equity increased by 7.132 euro, from 10.185 euro in 2022, to 17.286 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Andimed S.r.l.

Comments - Andimed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.